{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:00:48Z","timestamp":1777111248273,"version":"3.51.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-03932-6","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T11:04:54Z","timestamp":1739531094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of safety and efficacy of calcipotriol 0.005% cream versus terbinafine hydrochloride 1% cream in treatment of onychomycosis; a randomized split body comparative pilot study"],"prefix":"10.1007","volume":"317","author":[{"given":"Noha E.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doha F.","family":"Rabie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1590-8375","authenticated-orcid":false,"given":"Rania","family":"Abdelghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara M.","family":"Yaseen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"3932_CR1","first-page":"1","volume-title":"Topical nail products and Ungual Drug Delivery","author":"S Murdan","year":"2013","unstructured":"Murdan S (2013) The nail: anatomy, physiology, diseases and treatment. In: Murthy SN, Maibachm HI (eds) Topical nail products and Ungual Drug Delivery, 1st edn. CRC, FL, USA, pp 1\u201336","edition":"1"},{"key":"3932_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s40266-021-00917-8","volume":"39","author":"AK Gupta","year":"2022","unstructured":"Gupta AK, Venkataraman M, Talukder M (2022) Onychomycosis in older adults: prevalence, diagnosis, and management. Drugs Aging 39:191\u2013198","journal-title":"Drugs Aging"},{"key":"3932_CR3","doi-asserted-by":"crossref","unstructured":"Sigurgeirsson B, Baran R (2014) The prevalence of onychomycosis in the global population: A literature study. J Eur Acad Dermatol Venereol; 28: 1480\u201391.","DOI":"10.1111\/jdv.12323"},{"key":"3932_CR4","doi-asserted-by":"crossref","unstructured":"Gupta AK, Gupta G, Jain HC, Lynde CW, Foley K.A, Daigle D. The prevalence of unsuspected onychomycosis and its causative organisms in a multicentre Canadian sample of 30000 patients visiting physicians\u2019 offices. J Eur Acad Dermatol Venereol 2016; 30: 1567\u201372","DOI":"10.1111\/jdv.13677"},{"key":"3932_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1468-3083.2004.00851.x","volume":"18","author":"B Sigurgeirsson","year":"2004","unstructured":"Sigurgeirsson B, Steingrimsson O (2004) Risk factors associated with onychomycosis. J Eur Acad Dermatol Venereol 18:48\u201351","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3932_CR6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1067\/mjd.2000.107754","volume":"43","author":"MA Ghannoum","year":"2000","unstructured":"Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R et al (2000) A large-scale north American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol 43:641\u2013648","journal-title":"J Am Acad Dermatol"},{"key":"3932_CR7","doi-asserted-by":"crossref","unstructured":"Welsh O, Vera-Cabrera L, Welsh E, Onychomycosis (2010) Clin Dermatol 28:151\u2013159","DOI":"10.1016\/j.clindermatol.2009.12.006"},{"key":"3932_CR8","doi-asserted-by":"publisher","unstructured":"Maskan Bermudez N, Rodr\u00edguez-Tamez G, Perez S, Tosti A, Onychomycosis (2023) Old and New. J Fungi (Basel) 12(5):559. https:\/\/doi.org\/10.3390\/jof9050559","DOI":"10.3390\/jof9050559"},{"key":"3932_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/BF00449429","volume":"2","author":"DP Lubeck","year":"1993","unstructured":"Lubeck DP, Patrick DL, McNulty P, Fifer SK, Birnbaum J (1993) Quality of life of persons with onychomycosis. Qual Life Res 2:341\u2013348","journal-title":"Qual Life Res"},{"issue":"43","key":"3932_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1365-2133.1994.tb06087.x","volume":"130","author":"RK Scher","year":"1994","unstructured":"Scher RK (1994) Onychomycosis is more than a cosmetic problem. Br J Dermatol 130(43):15","journal-title":"Br J Dermatol"},{"key":"3932_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1001\/archderm.138.3.353","volume":"138","author":"B Sigurgeirsson","year":"2002","unstructured":"Sigurgeirsson B, Olafsson JH, Steinsson JB, Paul C, Billstein S, Evans EG (2002) Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study. Arch Dermatol 138:353\u2013357","journal-title":"Arch Dermatol"},{"issue":"65","key":"3932_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1046\/j.1365-2133.149.s65.5.x","volume":"149","author":"RK Scher","year":"2003","unstructured":"Scher RK, Baran R (2003) Onychomycosis in clinical practice: factors contributing to recurrence. Br J Dermatol 149(65):5\u20139","journal-title":"Br J Dermatol"},{"key":"3932_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.7547\/87507315-90-10-495","volume":"90","author":"AK Gupta","year":"2000","unstructured":"Gupta AK, Joseph WS (2000) Ciclopirox 8% nail lacquer in the treatment of onychomycosis of the toenails in the United States. J Am Podiatr Med Assoc 90:495\u2013401","journal-title":"J Am Podiatr Med Assoc"},{"issue":"1","key":"3932_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1365-2230.1992.tb00277.x","volume":"17","author":"J Lauharanta","year":"1992","unstructured":"Lauharanta J (1992) Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly. Clin Exp Dermatol 17(1):41\u201343","journal-title":"Clin Exp Dermatol"},{"key":"3932_CR15","first-page":"186","volume":"12","author":"EH Tschen","year":"2013","unstructured":"Tschen EH, Bucko AD, Oizumi N, Kawabata H, Olin JT, Pillai R (2013) Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study. J Drugs Dermatol 12:186\u2013192","journal-title":"J Drugs Dermatol"},{"key":"3932_CR16","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","volume":"68","author":"BE Elewski","year":"2013","unstructured":"Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H et al (2013) Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies. J Am Acad Dermatol 68:600\u2013608","journal-title":"J Am Acad Dermatol"},{"key":"3932_CR17","doi-asserted-by":"crossref","unstructured":"Gupta AK, Surprenant MS, Kempers SE, Pariser DM, Rensfeldt K, Tavakkol A (2021) Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study. J Am Acad Dermatol; 85(1):95\u2013104.","DOI":"10.1016\/j.jaad.2020.06.055"},{"key":"3932_CR18","doi-asserted-by":"crossref","unstructured":"Baran R, Tosti A, Hartmane I, Altmeyer P, Hercogova J, Koudelkova V. An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis. J Eur Acad Dermatol Venereol 2009; 23: 773\u201381","DOI":"10.1111\/j.1468-3083.2009.03164.x"},{"issue":"1\u20132","key":"3932_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2009.10.002","volume":"384","author":"R Elkeeb","year":"2010","unstructured":"Elkeeb R, AliKhan A, Elkeeb L, Hui X, Maibach HI (2010) Transungual drug delivery: current status. Int J Pharm 384(1\u20132):1\u20138","journal-title":"Int J Pharm"},{"key":"3932_CR20","unstructured":"Kawa N, Lee KC, Anderson RR, Garibyan L, Onychomycosis (2019) A review of New and Emerging Topical and device-based treatments. J Clin Aesthet Dermatol 12(10):29\u201334"},{"key":"3932_CR21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1517\/13543780902810352","volume":"18","author":"S Kumar","year":"2009","unstructured":"Kumar S, Kimball AB (2009) New antifungal therapies for the treatment of onychomycosis. Expert Opin Investig Drugs 18:727\u2013734","journal-title":"Expert Opin Investig Drugs"},{"key":"3932_CR22","doi-asserted-by":"crossref","unstructured":"Thatai P, Sapra B (2017) Transungual Gel of Terbinafine Hydrochloride for the Management of Onychomycosis: Formulation, Optimization, and Evaluation. AAPS Pharm Sci Tech; 18(6):2316-28.","DOI":"10.1208\/s12249-017-0711-7"},{"key":"3932_CR23","doi-asserted-by":"crossref","unstructured":"Tosti A, Piraccini B, Cameli N, Kokely F, Plozzer C, Cannata G,. Calcipotriol ointment in nail psoriasis: a controlled double blind comparison with betamethasone dipropionate and salicylic acid. Br J Dermatol 1998; 139(4): 655\u20139","DOI":"10.1046\/j.1365-2133.1998.02462.x"},{"issue":"8","key":"3932_CR24","first-page":"912","volume":"13","author":"L Kole","year":"2014","unstructured":"Kole L, Cantrell W, Elewski B (2014) A randomized, double-blinded trial evaluating the efficacy and tolerability of vectical ointment (calcitriol 3 mcg\/g ointment) when compared to betamethasone diproprionate ointment (64\u00a0mg\/g) in patients with nail psoriasis. J Drugs Dermatol 13(8):912\u2013915","journal-title":"J Drugs Dermatol"},{"key":"3932_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/clinids\/24.2.235","volume":"24","author":"JH Rex","year":"1997","unstructured":"Rex JH, Pfaller MA, Galgiani JN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA et al (1997) Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin Infect Dis 24:235\u2013247","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3932_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1468-3083.2005.01284.x","volume":"19","author":"M Lecha","year":"2005","unstructured":"Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R (2005) Taskforce on Onychomycosis E. Treatment options\u2013 development of consensus guidelines. J Eur Acad Dermatol Venereol 19(1):25\u201333","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"3932_CR27","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/archdermatol.2011.267","volume":"147","author":"C Carney","year":"2011","unstructured":"Carney C, Tosti A, Daniel R, Scher R, Rich P, DeCoster J et al (2011) A new classification system for grading the severity of onychomycosis: Onychomycosis Severity Index. Arch Dermatol 147(11):1277\u20131282","journal-title":"Arch Dermatol"},{"key":"3932_CR28","first-page":"28","volume-title":"Medical mycology: current trends and Future prospects","author":"SR Lipner","year":"2015","unstructured":"Lipner SR, Scher RK (2015) Onychomycosis: diagnosis and therapy. Medical mycology: current trends and Future prospects, 1st edn. CRC, Boca Raton, FL, USA, p 28","edition":"1"},{"issue":"9","key":"3932_CR29","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1111\/jdv.16394","volume":"34","author":"A Gupta","year":"2020","unstructured":"Gupta A, Stec N, Summerbell R, Shear N, Piguet V, Tosti A (2020) Onychomycosis: a review. J Eur Acad Dermatol Venereol 34(9):1972\u20131990","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3932_CR30","doi-asserted-by":"crossref","unstructured":"Lipner S, Scher R, Onychomycosis (2019) Treatment and prevention of recurrence. J Am Acad Dermatol 80(4):853\u2013867","DOI":"10.1016\/j.jaad.2018.05.1260"},{"issue":"1","key":"3932_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2174\/1872213X13666191026090713","volume":"14","author":"A Leung","year":"2020","unstructured":"Leung A, Lam J, Leong K, Hon K, Barankin B, Leung A et al (2020) Onychomycosis: an updated review. Recent Pat Inflamm Allerg drug Discov 14(1):32\u201345","journal-title":"Recent Pat Inflamm Allerg drug Discov"},{"key":"3932_CR32","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.4049\/jimmunol.173.5.2909","volume":"173","author":"TT Wang","year":"2004","unstructured":"Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J et al (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173:2909\u20132912","journal-title":"J Immunol"},{"key":"3932_CR33","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/j.0022-202X.2005.23687.x","volume":"124","author":"G Weber","year":"2005","unstructured":"Weber G, Heilborn JD, Chamorro Jimenez CI, Hammarsj\u00f6 A, T\u00f6rm\u00e4 H, St\u00e5hle M (2005) Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol 124:1080\u20131082","journal-title":"J Invest Dermatol"},{"issue":"4","key":"3932_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1600-0625.2009.00997.x","volume":"19","author":"JD Heilborn","year":"2010","unstructured":"Heilborn JD, Weber G, Gr\u00f6nberg A, Dieterich C, St\u00e5hle M (2010) Topical treatment with the vitamin D analogue calcipotriol enhances the upregulation of the antimicrobial protein hCAP18\/LL-37 during wounding in human skin in vivo. Exp Dermatol 19(4):332\u2013338","journal-title":"Exp Dermatol"},{"key":"3932_CR35","first-page":"91","volume":"306","author":"MH Braf","year":"2006","unstructured":"Braf MH, Gallo RL (2006) Antimicrobial peptides: an essential component of the skin defensive barrier. Curr Top Microbiol Immunol 306:91\u201310","journal-title":"Curr Top Microbiol Immunol"},{"key":"3932_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.0022-202X.2005.23713.x","volume":"125","author":"B Lopez-Garcia","year":"2005","unstructured":"Lopez-Garcia B, Lee PH, Yamasaki K, Gallo RL (2005) Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J Invest Dermatol 125:108\u2013115","journal-title":"J Invest Dermatol"},{"issue":"1","key":"3932_CR37","doi-asserted-by":"publisher","first-page":"13430","DOI":"10.1038\/s41598-018-31823-6","volume":"8","author":"C Guttmann-Gruber","year":"2018","unstructured":"Guttmann-Gruber C, Tockner B, Scharler C, H\u00fcttner C, Common JE, Tay ASL et al (2018) Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes. Sci Rep 8(1):13430","journal-title":"Sci Rep"},{"key":"3932_CR38","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tibtech.2011.05.001","volume":"29","author":"LT Nguyen","year":"2011","unstructured":"Nguyen LT, Haney EF, Vogel HJ (2011) The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol 29:464\u2013472","journal-title":"Trends Biotechnol"},{"key":"3932_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3109\/03009734.2014.899278","volume":"119","author":"M Malmsten","year":"2014","unstructured":"Malmsten M (2014) Antimicrobial peptides. Ups J Med Sci 119:199\u2013104","journal-title":"Ups J Med Sci"},{"issue":"1","key":"3932_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/sj.jid.5701043","volume":"128","author":"M Carretero","year":"2008","unstructured":"Carretero M, Esc\u00e1mez MJ, Garc\u00eda M, Duarte B, Holgu\u00edn A, Retamosa L et al (2008) In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J Invest Dermatol 128(1):223\u2013236","journal-title":"J Invest Dermatol"},{"issue":"11","key":"3932_CR41","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1172\/JCI17545","volume":"111","author":"R Koczulla","year":"2003","unstructured":"Koczulla R, von Degenfeld G, Kupatt C, Kr\u00f6tz F, Zahler S, Gloe T et al (2003) An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18. J Clin Invest 111(11):1665\u20131672","journal-title":"J Clin Invest"},{"issue":"8","key":"3932_CR42","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/mmy\/myaa014","volume":"58","author":"M van Eijk","year":"2020","unstructured":"van Eijk M, Boerefijn S, Cen L, Rosa M, Morren MJH, van der Ent CK (2020) Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds. Med Mycol 58(8):1073\u20131084","journal-title":"Med Mycol"},{"key":"3932_CR43","first-page":"e129","volume":"12","author":"S Segaert","year":"2013","unstructured":"Segaert S, Ropke M (2013) The Biological Rationale for Use of Vitamin D Analogues in combination with corticosteroids for the Topical Treatment of Plaque Psoriasis. J Drugs Dermatol 12:e129\u2013e137","journal-title":"J Drugs Dermatol"},{"key":"3932_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0923-1811(02)00136-6","volume":"31","author":"H Takahashi","year":"2003","unstructured":"Takahashi H, Ibe M, Kinouchi M, Ishida-Yamamoto A, Hashimoto Y et al (2003) Similarly potent action of 1,25-Dihydroxyvitamin D3 and its analogues, Tacalcitol, Calcipotriol, and Maxacalcitol on Normal Human keratinocyte proliferation and differentiation. J Dermatol Sci 31:21\u201328","journal-title":"J Dermatol Sci"},{"key":"3932_CR45","doi-asserted-by":"publisher","first-page":"e972","DOI":"10.1111\/j.1365-2230.2009.03518.x","volume":"34","author":"R Tiberio","year":"2009","unstructured":"Tiberio R, Bozzo C, Pertusi G, Graziola F, Gattoni M, Griffanti P et al (2009) Calcipotriol induces apoptosis in psoriatic keratinocytes. Clin Exp Dermatol 34:e972\u2013e974","journal-title":"Clin Exp Dermatol"},{"key":"3932_CR46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/00015550410025930","volume":"84","author":"ME Franssen","year":"2004","unstructured":"Franssen ME, de Jongh GJ, van Erp PE, van de Kerkhof PC (2004) A Left\/Right Comparison of Twice-Daily Calcipotriol Ointment and Calcitriol Ointment in patients with psoriasis: the Effect on keratinocyte subpopulations. Acta Derm Venereol 84:195\u2013200","journal-title":"Acta Derm Venereol"},{"key":"3932_CR47","first-page":"46","volume":"3","author":"P De Doncker","year":"1997","unstructured":"De Doncker P (1997) Pharmacokinetics of oral antifungal agents. Dermatol Ther 3:46\u201357","journal-title":"Dermatol Ther"},{"key":"3932_CR48","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1128\/AAC.42.5.1057","volume":"42","author":"NS Ryder","year":"1998","unstructured":"Ryder NS, Wagner S, Leitner I (1998) In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts. Antimicrob Agents Chemother 42:1057\u20131061","journal-title":"Antimicrob Agents Chemother"},{"key":"3932_CR49","doi-asserted-by":"crossref","unstructured":"Hu YX, Hu YQ, Lu Y, Huang SY, Liu KX, Han X et al (2017) A Case Report of Penile infection caused by Fluconazole- and Terbinafine-Resistant Candida albicans. Mycopathol 182:397\u2013402","DOI":"10.1007\/s11046-016-0070-z"},{"issue":"4","key":"3932_CR50","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1080\/09546634.2021.1942421","volume":"33","author":"AK Gupta","year":"2022","unstructured":"Gupta AK, Venkataraman M (2022) Antifungal resistance in superficial mycoses. J Dermatol Treat 33(4):1888\u20131895","journal-title":"J Dermatol Treat"},{"key":"3932_CR51","doi-asserted-by":"crossref","unstructured":"Corte L, Roscini L, Colabella C, Tascini C, Leonildi A, Sozio E et al (2016) Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts. Sci Rep; 6","DOI":"10.1038\/srep26860"},{"key":"3932_CR52","doi-asserted-by":"crossref","unstructured":"Cavalheiro M, Teixeira MC (2018) Candida Biofilms: threats, challenges, and promising strategies. Front Med; 5","DOI":"10.3389\/fmed.2018.00028"},{"key":"3932_CR53","doi-asserted-by":"crossref","unstructured":"Kano R, Hsiao YH, Han HS, Chen C, Hasegawa A, Kamata H (2018) Resistance Mechanism in a Terbinafine-Resistant Strain of Microsporum canis. Mycopathol;183(3):623-7. Erratum in: Mycopathol 2018; 183(3):629","DOI":"10.1007\/s11046-018-0242-0"},{"issue":"12","key":"3932_CR54","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/myc.13648","volume":"66","author":"D Navarro-P\u00e9rez","year":"2023","unstructured":"Navarro-P\u00e9rez D, Garc\u00eda-Oreja S, Tard\u00e1guila-Garc\u00eda A, Le\u00f3n-Herce D, \u00c1lvaro-Afonso FJ, L\u00e1zaro-Mart\u00ednez JL (2023) Microbiological culture combined with PCR for the diagnosis of onychomycosis: descriptive analysis of 121 patients. Mycoses 66(12):1045\u20131049","journal-title":"Mycoses"},{"issue":"2","key":"3932_CR55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1067\/S0190-9622(03)01480-4","volume":"49","author":"JM Weinberg","year":"2003","unstructured":"Weinberg JM, Koestenblatt EK, Tutrone WD, Tishler HR, Najarian L (2003) Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol Agosto De 49(2):193\u2013197","journal-title":"J Am Acad Dermatol Agosto De"},{"issue":"4","key":"3932_CR56","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11046-009-9212-x","volume":"168","author":"JA Jayatilake","year":"2009","unstructured":"Jayatilake JA, Tilakaratne WM, Panagoda GJ (2009) Candidal onychomycosis: a mini-review. Mycopathol 168(4):165\u2013173. https:\/\/doi.org\/10.1007\/s11046-009-9212-x","journal-title":"Mycopathol"},{"issue":"2","key":"3932_CR57","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mycmed.2014.12.001","volume":"25","author":"S Nouripour-Sisakht","year":"2015","unstructured":"Nouripour-Sisakht S, Mirhendi H, Shidfar MR, Ahmadi B, Rezaei-Matehkolaei A, Geramishoar M et al (2015) Aspergillus species as emerging causative agents of onychomycosis. J Mycol Med 25(2):101\u2013107. https:\/\/doi.org\/10.1016\/j.mycmed.2014.12.001","journal-title":"J Mycol Med"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03932-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-03932-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03932-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T22:40:18Z","timestamp":1739572818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-03932-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3932"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-03932-6","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of Faculty of Medicine, Al Fayoum University, Egypt. It was reviewed by the Institutional Reviewing Board with IRB approval number (M602, 30\/8\/2022) and conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}},{"value":"Informed written consent was obtained from all patients prior to enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figs.\u00a0,  and .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"402"}}